Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
CTKB is expected to report earnings to fall 105.00% to 0 cents per share on March 04
Q4'25
Est.
$0.00
Q3'25
Missed
by $0.01
Q2'25
Est.
$-0.04
Q1'25
Missed
by $0.07
Q4'24
Beat
by $0.01
The last earnings report on November 05 showed earnings per share of -3 cents, missing the estimate of -2 cents. With 519.67K shares outstanding, the current market capitalization sits at 615.03M.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. CTKB showed earnings on November 05, 2025. You can read more about the earnings report here.